M
Marepalli B. Rao
Researcher at University of Cincinnati
Publications - 75
Citations - 1280
Marepalli B. Rao is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 19, co-authored 66 publications receiving 1038 citations.
Papers
More filters
Journal ArticleDOI
Exposure assessment models for elemental components of particulate matter in an urban environment: A comparison of regression and random forest approaches.
Cole Brokamp,Roman Jandarov,Marepalli B. Rao,Grace K. LeMasters,Grace K. LeMasters,Patrick H. Ryan,Patrick H. Ryan +6 more
TL;DR: A novel land use random forest (LURF) model is developed and its accuracy and precision is compared to a LUR model for elemental components of PM in the urban city of Cincinnati, Ohio to provide more accurate exposure assessment.
Journal ArticleDOI
Survival of patients with small cell carcinoma of the prostate during 1973-2003: a population-based study.
TL;DR: In this paper, the authors used the Kaplan-Meier method for estimating survival, and Cox proportional hazard regression modelling to evaluate prognostic variables, and found age, concomitant low-grade prostatic adenocarcinoma, and stage of the disease to be the strongest predictors of survival.
Journal ArticleDOI
Effect of scaffold material, construct length and mechanical stimulation on the in vitro stiffness of the engineered tendon construct
Victor S. Nirmalanandhan,Marepalli B. Rao,Jason T. Shearn,Natalia Juncosa-Melvin,Cindi Gooch,David L. Butler +5 more
TL;DR: The authors' results indicate that all three treatment factors influenced construct linear stiffness, and increasing the length of the construct had the greatest effect on the stiffness compared to introducing mechanical stimulation or changing the scaffold material.
Journal ArticleDOI
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.
Rebecca A. Marsh,Marepalli B. Rao,Aharon Gefen,Denise Bellman,Parinda A. Mehta,Pooja Khandelwal,Sharat Chandra,Sonata Jodele,Kasiani C. Myers,Michael Grimley,Christopher E. Dandoy,Javier El-Bietar,Ashish R Kumar,Tom Leemhuis,Kejian Zhang,Jack J. Bleesing,Michael B. Jordan,Alexandra H. Filipovich,Stella M. Davies +18 more
TL;DR: A retrospective study of 206 patients with metabolic diseases, non-Fanconi anemia marrow failure disorders, and primary immune deficiencies who underwent 210 consecutive RIC HCT procedures at Cincinnati Children's Hospital concludes that alemtuzumab, fludarabine, and melphalan Ric HCT offers good results for many patients and that the risk of developing mixed chimerism is influenced by underlying diagnosis, graft source, and alem TZM dosing.
Journal ArticleDOI
Mechanical stimulation of tissue engineered tendon constructs: effect of scaffold materials.
Victor S. Nirmalanandhan,Matthew R. Dressler,Jason T. Shearn,Natalia Juncosa-Melvin,Marepalli B. Rao,Cynthia Gooch,Gino Bradica,David L. Butler +7 more
TL;DR: Collagen sponge rather than collagen gel facilitates how cells respond to a mechanical stimulus and may be the scaffold of choice in mechanical stimulation studies to produce functional tissue engineered structures.